JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Appendix 1 - Changes to donor selection guidelines

Section 1
Changes introduced with TDSG-BM 203 Release 02 from TDSG-BM 202 Release 03

There have been changes made to the following entries:

Acupuncture
Age
Animal Bite
Ankylosing Spondylitis
Anti-Androgens
Antibiotic Therapy
Antidepressant Therapy
Arthritis
Autoimmune Disease
Back Problems
Beta Blockers
Bipolar Disorder
Bleeding Disorder
Blood Pressure - High
Blood Volume Estimation
Cardiovascular Disease
Chikungunya Virus
Chlamydia
Cirrhosis
Colitis
Communication Difficulties
Depression
Dermatitis
Disabled Donor
Disease of Unknown Aetiology
Elliptocytosis
Endocarditis
Endoscopy
Episcleritis
Eye Disease
Gall Bladder Disease
G-CSF
German Measles
Haemoglobin Disorders
Haemolytic Anaemia
Hepatitis B
Hepatitis B - Post Immunization
Hepatitis C
Hepatitis of Unknown Origin
Hereditary Elliptocytosis
Hereditary Spherocytosis
Hormone Replacement Therapy
Immune Thrombocytopenia
Immunoglobulin Therapy
Immunosuppression
Infection - Chronic
Inflammatory Eye Disease
Inoculation Injury
Jaundice
Laminectomy
Latex Allergy
Malaria
Mental Health Problems
Myeloproliferative Syndrome
Pituitary Extract - Human
Platelet Disorder
Polymyalgia Rheumatica
Prion Associated Diseases
Psoriasis
Pyruvate Kinase Deficiency
Rheumatoid Arthritis
Scleritis
Sexually Transmitted Disease
Shingles
Sickle-Cell Trait
Skin Disease
Steroid Therapy
Subacute Bacterial Endocarditis
Surgery
Syphilis
Temporal Arteritis
Thrombocytosis
Thyroid Disease
Tigason
Tissue and Organ Recipients
Transfusion
Weight
West Nile Virus

 

Section 2
Changes to TDSG-BM 203 after Release 02

See: Latest Updates


This appendix was last updated in TDSG-BM Edition 203, Release 02